4-1BBL costimulation retrieves CD28 expression in activated T cells

Cellular Immunology

Volumn 256, Issue 1-2, 2009, Pages 39-46

  Habib Agahi, Mojtaba ^a,b   Jaberipour, Mansooreh ^c   Searle, Peter F ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

4 1BBL; CD137; CD28 kinetics; CD80; CD86; Costimulation; T cell

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; CD137 ANTIGEN; CD137 LIGAND; CD28 ANTIGEN; CD3 ANTIBODY; CD86 ANTIGEN;

ADENOVIRUS; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LUNG CARCINOMA; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS RECOMBINANT;

4-1BB LIGAND; ADENOVIRIDAE; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; GENETIC VECTORS; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 61849174765     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.01.003     Document Type: Article

References (38)

1. Zheng Y., Zha Y., and Gajewski T.F. Molecular regulation of T-cell anergy. EMBO Rep. 9 (2008) 50-55
2. Andres P.G., Howland K.C., Dresnek D., Edmondson S., Abbas A.K., and Krummel M.F. CD28 signals in the immature immunological synapse. J. Immunol. 172 (2004) 5880-5886
3. Bromley S.K., Iaboni A., Davis S.J., Whitty A., Green J.M., Shaw A.S., Weiss A., and Dustin M.L. The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2 (2001) 1159-1166
4. Wetzel S.A., McKeithan T.W., and Parker D.C. Live-cell dynamics and the role of costimulation in immunological synapse formation. J. Immunol. 169 (2002) 6092-6101
5. Viola A., and Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273 (1996) 104-106
6. Miceli M.C., Moran M., Chung C.D., Patel V.P., Low T., and Zinnanti W. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin. Immunol. 13 (2001) 115-128
7. Bonnevier J.L., and Mueller D.L. Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J. Immunol. 169 (2002) 6659-6663
8. Appleman L.J., Van Puijenbroek A.A., Shu K.M., Nadler L.M., and Boussiotis V.A. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 168 (2002) 2729-2736
9. Okkenhaug K., Wu L., Garza K.M., La R.J., Khoo W., Odermatt B., Mak T.W., Ohashi P.S., and Rottapel R. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2 (2001) 325-332
10. Dahl A.M., Klein C., Andres P.G., London C.A., Lodge M.P., Mulligan R.C., and Abbas A.K. Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes. J. Exp. Med. 191 (2000) 2031-2038
11. Lewis D.E., Merched-Sauvage M., Goronzy J.J., Weyand C.M., and Vallejo A.N. Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription. J. Biol. Chem. 279 (2004) 29130-29138
12. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 205 (2005) 158-169
13. Schirmer M., Goldberger C., Wurzner R., Duftner C., Pfeiffer K.P., Clausen J., Neumayr G., and Falkenbach A. Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res. 4 (2002) 71-76
14. Bryl E., Vallejo A.N., Weyand C.M., and Goronzy J.J. Down-regulation of CD28 expression by TNF-alpha. J. Immunol. 167 (2001) 3231-3238
15. Vallejo A.N., Bryl E., Klarskov K., Naylor S., Weyand C.M., and Goronzy J.J. Molecular basis for the loss of CD28 expression in senescent T cells. J. Biol. Chem. 277 (2002) 46940-46949
16. Fann M., Chiu W.K., Wood III W.H., Levine B.L., Becker K.G., and Weng N.P. Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol. Rev. 205 (2005) 190-206
17. Alderson M.R., Smith C.A., Tough T.W., vis-Smith T., Armitage R.J., Falk B., Roux E., Baker E., Sutherland G.R., and Din W.S. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24 (1994) 2219-2227
18. Takahashi C., Mittler R.S., and Vella A.T. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162 (1999) 5037-5040
19. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat. Rev. Immunol. 3 (2003) 609-620
20. Pollok K.E., Kim Y.J., Zhou Z., Hurtado J., Kim K.K., Pickard R.T., and Kwon B.S. Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150 (1993) 771-781
21. Gilligan M.G., Knox P., Weedon S., Barton R., Kerr D.J., Searle P., and Young L.S. Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells. Gene Ther. 5 (1998) 965-974
22. Habib-Agahi M., Phan T.T., and Searle P.F. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells. Int. Immunol. 19 (2007) 1383-1394
23. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14 (1996) 233-258
24. Effros R.B., Boucher N., Porter V., Zhu X., Spaulding C., Walford R.L., Kronenberg M., Cohen D., and Schachter F. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29 (1994) 601-609
25. Eck S.C., Chang D., Wells A.D., and Turka L.A. Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Transplantation 64 (1997) 1497-1499
26. Berg M., and Zavazava N. Regulation of CD28 expression on CD8+ T cells by CTLA-4. J. Leukoc. Biol. 83 (2008)
27. Borthwick N.J., Lowdell M., Salmon M., and Akbar A.N. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int. Immunol. 12 (2000) 1005-1013
28. Compton H.L., and Farrell J.P. CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. J. Immunol. 168 (2002) 1302-1308
29. Salomon B., and Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19 (2001) 225-252
30. Waller E.C., McKinney N., Hicks R., Carmichael A.J., Sissons J.G., and Wills M.R. Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8(+) T cells. Blood 110 (2007) 4360-4366
31. Hippen K.L., Harker-Murray P., Porter S.B., Merkel S.C., Londer A., Taylor D.K., Bina M., Panoskaltsis-Mortari A., Rubinstein P., Van R.N., Golovina T.N., Suhoski M.M., Miller J.S., Wagner J.E., June C.H., Riley J.L., and Blazar B.R. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 112 (2008) 2847-2857
32. Suhoski M.M., Golovina T.N., Aqui N.A., Tai V.C., Varela-Rohena A., Milone M.C., Carroll R.G., Riley J.L., and June C.H. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol. Ther. 15 (2007) 981-988
33. + T cells: reversal by interleukin-12 stimulation. Blood 101 (2003) 3543-3549
34. Rogers P.R., Song J., Gramaglia I., Killeen N., and Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15 (2001) 445-455
35. Croft M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14 (2003) 265-273
36. Pulle G., Vidric M., and Watts T.H. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J. Immunol. 176 (2006) 2739-2748
37. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2 (2002) 116-126
38. -. J. Immunol. 178 (2007) 7710-7719